Inventor
BHAT LAXMINARAYAN
US42 patents
⚠️ This page may combine multiple inventors who share the name “BHAT LAXMINARAYAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
REVIVA PHARMACEUTICALS INC
17 patentsUS7989500B2Aug 2, 2011
Synthesis, methods of using, and compositions of cycloalkylmethylamines
REVIVA PHARMACEUTICALS INC11 citations91
US9238625B2Jan 19, 2016
Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives
REVIVA PHARMACEUTICALS INC3 citations72
US10441590B2Oct 15, 2019
Methods for treating pulmonary hypertension
REVIVA PHARMACEUTICALS INC2 citations63
US12053477B2Aug 6, 2024
Methods for treating pulmonary fibrosis
REVIVA PHARMACEUTICALS INC0 citations62
US9695116B2Jul 4, 2017
Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives
REVIVA PHARMACEUTICALS INC1 citations61
US9604944B2Mar 28, 2017
Arylpiperazine derivatives and methods of utilizing same
REVIVA PHARMACEUTICALS INC1 citations61
US9296681B2Mar 29, 2016
Cycloalkylmethylamines
REVIVA PHARMACEUTICALS INC2 citations61
US9255076B2Feb 9, 2016
Arylpiperazine derivatives and methods of utilizing same
REVIVA PHARMACEUTICALS INC2 citations61
US8980883B2Mar 17, 2015
Arylpiperazine derivatives and methods of utilizing same
REVIVA PHARMACEUTICALS INC1 citations61
US8859552B2Oct 14, 2014
Methods of utilizing arylpiperazine derivatives
REVIVA PHARMACEUTICALS INC1 citations61
US8669285B2Mar 11, 2014
Synthesis, methods of using, and compositions of cycloalkylmethylamines
REVIVA PHARMACEUTICALS INC2 citations61
US8372883B2Feb 12, 2013
Methods of using cycloalkylmethylamines
REVIVA PHARMACEUTICALS INC2 citations61
US9907803B2Mar 6, 2018
Methods for treating attention deficit hyperactivity disorder
REVIVA PHARMACEUTICALS INC1 citations52
US10035761B2Jul 31, 2018
Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives
REVIVA PHARMACEUTICALS INC0 citations51
US9975862B2May 22, 2018
Arylpiperazine derivatives and methods of utilizing same
REVIVA PHARMACEUTICALS INC0 citations51
US9302981B2Apr 5, 2016
Synthesis, methods of using, and compositions of cycloalkylmethylamines
REVIVA PHARMACEUTICALS INC0 citations51
US9096515B2Aug 4, 2015
Methods of using cycloalkylmethylamine derivatives
REVIVA PHARMACEUTICALS INC0 citations51
BHAT LAXMINARAYAN
11 patentsUS8188076B2May 29, 2012
Compositions, synthesis, and methods of utilizing arylpiperazine derivatives
BHAT LAXMINARAYAN7 citations91
US8604244B2Dec 10, 2013
Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives
BHAT LAXMINARAYAN6 citations83
US8445714B2May 21, 2013
Cycloalkylmethylamines
BHAT LAXMINARAYAN5 citations83
US8247420B2Aug 21, 2012
Compositions, synthesis, and methods of using quinolinone based atypical antipsychotic agents
BHAT LAXMINARAYAN8 citations78
US8580822B2Nov 12, 2013
Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors
BHAT LAXMINARAYAN2 citations61
US8431570B2Apr 30, 2013
Methods of utilizing arylpiperazine derivatives
BHAT LAXMINARAYAN1 citations61
US8247563B2Aug 21, 2012
Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors
BHAT LAXMINARAYAN2 citations61
US8207163B2Jun 26, 2012
Compositions, synthesis, and methods of using piperazine based antipsychotic agents
BHAT LAXMINARAYAN2 citations61
US8461154B2Jun 11, 2013
Methods of utilizing arylpiperazine derivatives
BHAT LAXMINARAYAN0 citations51
US8338632B2Dec 25, 2012
Cycloalkylmethylamines
BHAT LAXMINARAYAN0 citations51
US8575185B2Nov 5, 2013
Compositions, synthesis, and methods of utilizing quinazolinedione derivatives
BHAT LAXMINARAYAN0 citations46
XENOPORT INC
9 patentsUS7101912B2Sep 5, 2006
Carbidopa prodrugs and derivatives, and compositions and uses thereof
XENOPORT INC98 citations98
US7026351B2Apr 11, 2006
Cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs, compositions and uses thereof
XENOPORT INC17 citations93
US7662987B2Feb 16, 2010
Methods for synthesis of acyloxyalkyl compounds
XENOPORT INC13 citations84
US7053076B2May 30, 2006
Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
XENOPORT INC12 citations84
US7560483B2Jul 14, 2009
Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
XENOPORT INC7 citations74
US7727976B2Jun 1, 2010
Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
XENOPORT INC2 citations63
US7569576B2Aug 4, 2009
Cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs, compositions and uses thereof
XENOPORT INC2 citations63
US8017776B2Sep 13, 2011
Methods for synthesis of acyloxyalkyl compounds
XENOPORT INC0 citations52
US7868041B2Jan 11, 2011
Cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs, compositions and uses thereof
XENOPORT INC0 citations52